Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

MiMedx Group Inc MDXG

Healthcare Biotechnology

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.

NDAQ:MDXG - Post by User

MiMedx Group Inc

Bullboard Posts

Post by InsiderTraderon Nov 04, 2017 11:52am

149 Views

Post# 26905878

Media beginning to view Cohodes with Contempt

12 retweets12 likes
Gary Weiss‏Verified account @gary_weiss 15 hours ago

The outrage is phony and the battle is a self-aggrandizing effort by a failed fund manager to talk his book $STMP $MDXG $HCG $EIF $BAD $OSTK

2 replies2 likes